BDBM62555 3-Hydroxy-4-methyl-1-(1,2,5-trimethyl-piperidin-4-yl)-1,7-dihydro-pyrazolo[3,4-b]pyridin-6-one::4-methyl-1-(1,2,5-trimethyl-4-piperidinyl)-2,7-dihydropyrazolo[3,4-b]pyridine-3,6-dione::4-methyl-1-(1,2,5-trimethyl-4-piperidyl)-2,7-dihydropyrazolo[3,4-b]pyridine-3,6-quinone::4-methyl-1-(1,2,5-trimethylpiperidin-4-yl)-2,7-dihydropyrazolo[3,4-b]pyridine-3,6-dione::MLS000026795::SMR000013436::cid_651768

SMILES COCCNC(=O)c1ccc(N2CCCc3cc(C(=O)N4CCCCC4)cnc32)cc1F

InChI Key InChIKey=MVFIEUFRENOXDE-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62555   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62555BDBM62555(US12577217, Example 1-60)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent